Published online Sep 20, 2025. doi: 10.5662/wjm.v15.i3.97415
Revised: November 3, 2024
Accepted: December 2, 2024
Published online: September 20, 2025
Processing time: 280 Days and 18.5 Hours
Endoscopic ultrasound-guided fine-needle aspiration/biopsy (EUS-FNA/B) is the most common modality for tissue acquisition from pancreatic masses. Despite high specificity, sensitivity remains less than 90%. Auxiliary techniques like elas
To compare the diagnostic outcomes of auxiliary-EUS-FNA/B to standard EUS-FNA/B for pancreatic lesions.
The electronic databases of MEDLINE, EMBASE, and Scopus were searched from inception to February 2024 for all relevant studies comparing diagnostic outcomes of auxiliary-EUS-FNA/B to standard EUS-FNA/B for pancreatic lesions. A bivariate hierarchical model was used to perform the meta-analysis.
A total of 10 studies were identified. The pooled sensitivity, specificity, and area under the receiver-operated curve (AUROC) for standard EUS-FNA/B were 0.82 (95%CI: 0.79-0.85), 1.00 (95%CI: 0.96-1.00), and 0.97 (95%CI: 0.95-0.98), respectively. The pooled sensitivity, specificity, and AUROC for EUS-FNA/B with auxiliary techniques were 0.86 (95%CI: 0.83-0.89), 1.00 (95%CI: 0.94-1.00), and 0.96 (95%CI: 0.94-0.98), respectively. Comparing the two diagnostic modalities, sensitivity [Risk ratio (RR): 1.04, 95%CI: 0.99-1.09], specificity (RR: 1.00, 95%CI: 0.99-1.01), and diagnostic accuracy (RR: 1.03, 95%CI: 0.98-1.09) were comparable.
Analysis of the currently available literature did not show any additional advantage of EUS-FNA/B with auxiliary techniques for pancreatic solid lesions over standard EUS-FNA/B. Further randomized studies are required to demonstrate the benefit of auxiliary techniques before they can be recommended for routine practice.
Core Tip: Auxiliary techniques like elastography and contrast enhancement are being used during endoscopic ultrasound-guided fine-needle aspiration/biopsy (EUS-FNA/B) to guide tissue acquisition from viable tumor tissue and improve diagnostic outcomes. However, the present meta-analysis reported comparable sensitivity, specificity, and diagnostic accuracy between EUS-FNA/B with and without auxiliary techniques. Subgroup analysis of studies exclusively using contrast-enhanced harmonic-EUS-FNA/B, randomized studies, and studies reporting diagnostic outcomes after the first pass reported no difference between both modalities. Thus, using EUS-FNA/B with auxiliary techniques for pancreatic solid lesions does not provide any additional advantage over standard EUS-FNA/B.
